- Tytuł:
- A phase II evaluation of motesanib (AMG 706) in the treatment of persistent or recurrent ovarian, fallopian tube and primary peritoneal carcinomas: A Gynecologic Oncology Group study
- Autorzy:
- Źródło:
- In Gynecologic Oncology April 2013 129(1):86-91
Czasopismo naukowe